There were higher levels of MCP-4 in the plasma of patients with MCL and C LCL, but not S LCL and higher levels of MIP-1α in the plasma of C LCL, but not S LCL or MCL patients as compared to HNEC. This evidence concerns the gene CCL13 and mantle cell lymphoma.